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Abstract
Background: High throughput gene expression profiling (GEP) is becoming a routine technique
in life science laboratories. With experimental designs that repeatedly span thousands of genes and
hundreds of samples, relying on a dedicated database infrastructure is no longer an option.
GEP technology is a fast moving target, with new approaches constantly broadening the field
diversity. This technology heterogeneity, compounded by the informatics complexity of GEP
databases, means that software developments have so far focused on mainstream techniques,
leaving less typical yet established techniques such as Nylon microarrays at best partially supported.
Results: MAF (MicroArray Facility) is the laboratory database system we have developed for
managing the design, production and hybridization of spotted microarrays. Although it can support
the widely used glass microarrays and oligo-chips, MAF was designed with the specific
idiosyncrasies of Nylon based microarrays in mind. Notably single channel radioactive probes,
microarray stripping and reuse, vector control hybridizations and spike-in controls are all natively
supported by the software suite. MicroArray Facility is MIAME supportive and dynamically provides
feedback on missing annotations to help users estimate effective MIAME compliance. Genomic data
such as clone identifiers and gene symbols are also directly annotated by MAF software using
standard public resources. The MAGE-ML data format is implemented for full data export.
Journalized database operations (audit tracking), data anonymization, material traceability and user/
project level confidentiality policies are also managed by MAF.
Conclusion: MicroArray Facility is a complete data management system for microarray producers
and end-users. Particular care has been devoted to adequately model Nylon based microarrays.
The MAF system, developed and implemented in both private and academic environments, has
proved a robust solution for shared facilities and industry service providers alike.
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Background
Transcriptome surveying using microarrays has become
an established and widespread technique[1]. Although
glass based microarrays and oligonucleotide chips are
common in the gene expression profiling (GEP) land-
scape, Nylon supported microarrays coupled with radio-
active detection, either home made [2-9] or from
industrial suppliers [10-14], are an alternative still favored
by some researchers[15], including the NIH's National
Institute on Aging [16-19]. The resilience of this platform
can be explained by the easy setup of this technical com-
bination, its high sensitivity achieved without target
amplification[20], and its cost effectiveness[16]. Techno-
logical development for this platform is ongoing, as dem-
onstrated by a two 'isotope' dual channel variant that uses
real time emission integration[21].
Regular increase in microarray reporter densities together
with falls in unitary costs have meant experiments rou-
tinely generate tens of millions of data pieces to store,
search and analyze[22]. For all but occasional microarray
users, dedicated laboratory information management sys-
tems (LIMS) are now a requirement. Arguably one reason
bench scientists are yielding to laboratory databases is
increasing pressure from journal editors to have data
appropriately submitted to international repositories as a
prerequisite for publication[23].
Amongst the gene expression profiling LIMS that have
been reported [24-34], glass dual channel Cy5/Cy3 and
oligonucleotide chips are extremely well catered for. How-
ever, Nylon based microarrays are at best marginally sup-
ported by these software, with more substantial Nylon
support only to be found in commercial products[35].
Drawing on experience with a previous LIMS[36], the spe-
cific functionalities that we have found critical for com-
prehensive Nylon based microarrays modeling include
the ability to record so called 'vector' hybridizations
(quantitations of spotted reporter amounts), the stripping
and recycling of microarrays[37] and to model controls
spiked into RNA samples [20,38]. Finally, the pharmaceu-
tical industry manufacturing and regulatory rigor required
for the development of diagnostic applications are typi-
cally not of major concern in freely available LIMS.
Here we report the development of MAF (MicroArray
Facility), a LIMS designed to accommodate the following
desiderata:
-stringent quality control, traceability and audit tracking
to meet industrial requirements
-multi-platform support (i.e. Nylon, glass, and oligo-
based microarrays)
-rich data annotation for MIAME standard compatibil-
ity[39]
-support for oncogenomic projects (i.e. clinical data)
-dynamic cDNA reporter annotation using public data
banks (notably UNIGENE[40])
-MAGE-ML enabled[41]
-import robotic equipment files in native formats to
reduce error-prone reformatting
-multi-user privilege environment to promote data shar-
ing and ensure confidentiality.
The scope of MAF (as defined in [42]) is a local LIMS serv-
ing a community of researchers, such as found around
academic shared facilities or commercial array and service
providers. The MAF user interface is entirely web browser
contained, thus there is no technical contra-indication to
using MAF as a means to publish datasets over the Inter-
net. However one-stop shops for gene expression data
have innumerable advantages for public data mining[43];
thus we strongly recommend uploading public data to
international archives such as ArrayExpress[44],
CIBEX[45] or GEO[22] as a mechanism for publishing
data.
MAF is a LIMS sensu stricto in that it records, tracks, struc-
tures, searches and reports all information required to
establish gene expression profiles. High level downstream
data analyses are carried out by exporting selected data to
any of the myriad of dedicated analysis packages such as
Cluster[46], BioConductor[47], MeV[26] or ProfileSoft-
ware[48].
Implementation
MAF follows a client-server architecture implemented as a
web-based application, allowing simultaneous multi-user
access to a central database. Client browsers connect to an
Apache server in a Unix/Linux environment. The applica-
tion is entirely written in Perl; since the Perl packages rely
on the abstract DBI module, switching between different
Relational Database Management systems (RDBMS) is as
simple as changing a single line in the MAF configuration
file. MAF has been implemented, tested and validated for
the Oracle 8i and the PostgreSQL RDBMS. With Oracle 8i,
certain Oracle-specific features such as backup tools and
transportable table spaces can also be used. Having delib-
erately avoided RDBMS specific SQL syntax, we believe
that MAF is easily portable to other SQL database plat-
forms that have a Perl DBD driver.BMC Genomics 2006, 7:240 http://www.biomedcentral.com/1471-2164/7/240
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The relational database underlying MAF – composed of
2258 fields held in 215 tables – is called ELOGE. Its
schema extends the conceptual ArrayExpress design[44]
which integrates microarray design and manufacturing,
sample description, hybridization and data acquisition.
Through a 5-year development cycle, ELOGE was consid-
erably expanded to integrate fine grain modelling of wet
lab routine procedures such as plate management, PCR
quality control annotations, sequencing results, analytic
validation, and GLP (Good Laboratory Practices) compli-
ant protocols. The database scheme is designed to avoid
computation-intensive queries and optimize user inter-
face responsiveness.
MAF is accompanied by two complementary software
modules (Fig. 1): the Gene Finder (GF) and Clone
Chooser (CC) which respectively manage gene and clone
lists, as well as provide effective mapping from one to the
other. Genomic data relevant to all three modules are
imported into ELOGE every two months from several
commonly used public databases (GENBANK EST, UNI-
GENE, SWISSPROT, ENTREZ GENE, GO and REFSEQ),
allowing automatic and thorough annotation of genes
and cDNA clones. Together, the MAF, GF and CC modules
constitute a package called Discovery Software.
MAF user data are collected through web form cascades
(Fig. 2). Where appropriate (e.g. array layouts or image
quantitations) data files are uploaded using background
queue processing to avoid tying-up the interface. Many
instrument and third party software data files are thus
directly imported using a large set of data formatting driv-
ers (Table 1). MAF web forms can be used to add, update
or view data. However, browsing MAF data is best
achieved through a collection of hyper linked data reports
specific for each step of GEP processing (Table 2).
The Laboratory Information Management System (LIMS) is articulated around a relational database (ELOGE) Figure 1
The Laboratory Information Management System (LIMS) is articulated around a relational database (ELOGE). Users manage 
gene lists, clone lists and microarray experiments through three software modules (Gene Finder, Clone Chooser and Microar-
ray Facility respectively). Reporter annotation is achieved by importing genomic context data from public databases. Stored 
data can be queried and exported for analysis by appropriate third party software.
MicroArray Facility
ELOGE
Database
Clone Chooser
Clone List Management
cDNA reporters
Import/export/combine lists,
annotate with Genomic Data
Instrument Interface
Robot input/output control
Pipetting, spotting &
scanning stations
Biological & Clinical Data
Sample annotation &
patient follow-up
Anonymize, controlled
vocabularies
Experimental Data
Gene expression profiling
Array manufacture, sample
processing,hybridization,
image quantification
Gene Finder
Gene List Management
UNIGENE clusters
Import/export/combine lists,
annotate with Genomic Data
Genomic Data
Import public databases
UNIGENE, SWISSPROT,
GENBANK EST, REFSEQ,
ENTREZ GENE & GO
Data Analysis
Third Party Software
BioConductor, Cluster,
MeV, ProfileSoftware etc.BMC Genomics 2006, 7:240 http://www.biomedcentral.com/1471-2164/7/240
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Confidentiality is ensured through user login/password
authentication and project containers. Access to a project's
objects (arrays, plates, hybridizations, quantitations etc.)
is controlled by the project owner through read, write,
update, and delete independent privileges. Unique trans-
action ID's for each request, inactivity time-outs, enforced
single user sessions and SSL network encryption complete
the MAF security strategy.
Results and discussion
Clone library management
MAF clone management models the laboratory proce-
dures for clone handling through wells, plates and plate
sets. The LIMS precisely tracks clones from the resource
plate to the array through replication, reorganisation,
amplification and spotting steps.
Since plate handling is a cornerstone of GEP experimental
work, much effort has been devoted to MAF's ergonomics
and the minimization of manual data entry. For instance
figure 3 shows the "PCR run" form used to enter quality
control data from gel migrations of PCR amplifications.
This synoptic side by side visualization of the gel picture
with the colour coded annotated plate has allowed sys-
tematic verification of at least 10% of the plates before
every plate set manipulation, without adversely affecting
efficiency. Following this PCR quality control annotation,
MAF can not only directly produce a reorganisation work
list for the plate handling workstation (e.g. Tecan), but
also verify and validate the reorganisation by comparing
its original work-list with the trace file summarizing the
work actually carried out by the work station.
Another example of MAF's routine quality controls is the
update of sequence verified clone identities by monthly
BLAST analysis and checking of clone to UNIGENE cluster
associations.
Microarray production
MAF manages every step of array production from abstract
print type and array type definitions to batch production
runs of physical arrays. A custom produced array design
can be created by directly uploading layout definition files
from spotting robots (e.g. Microgrid II or GMS), hence
avoiding error-prone manual entry of the array design.
Bypassing printing steps, microarrays or even oligo-chips
User data is collected through dedicated web form cascades Figure 2
User data is collected through dedicated web form cascades. This example shows the Array Type definition form, which 
includes a "vector analytic validation" field specific to Nylon filters.BMC Genomics 2006, 7:240 http://www.biomedcentral.com/1471-2164/7/240
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from third party providers can also be loaded into MAF,
albeit with less detailed annotation at the array design
level.
In the case of Nylon based arrays, MAF manages the "vec-
tor probe hybridisation" post-production quality control.
This step measures the quantity of reporter material
bound at each spot through batch hybridisation of filters
with a labelled oligonucleotide (the sequence of which is
common to every spotted clone), followed by filter strip-
ping.
Every array produced can be tracked down to the projects
and hybridizations in which it has been used.
Expression profiling data user submission
MAF data is partitioned into projects containing one or
more experiments. An experiment ties together any
number of hybridizations, usually all undertaken as part
of the same experimental design. Experimental data sub-
mission follows the flow leading from biological samples
to RNA extraction, labelling, hybridization, scanning,
image feature extraction, and finally normalisation of
measurements.
Table 1: Equipment and third party software which are directly compatible with Microarray Facility.
Operations Software/Workstation File format
Plate handling Tecan Text
Arraying Biogrid MAF web form
GeneMachines Text
Affymetrix 417 (ex GMS 417) Text
Microgrid II (Genomic Solutions) CSV
Generic Tabulated text
Image acquisition Raytest TINA (agarose gels)
Generic
PCB + BMP
BMP/TIF/IMG+INF
Quantitation ArrayGauge 2.1 (Fuji) Text
BZScan 1.0 (INSERM) Text
GenePix 3.0 (Axon) Text
Imagene 4.0 (BioDiscovery) Text
ProfileSoftware Corporate/Cancer (Ipsogen) Text
Generic Tabulated text
Normalization ProfileSoftware Corporate (Ipsogen) Text
Generic Tabulated text
Enclosures Generic Any (PDF, Text, DOC etc.)
Interfacing is through upload of output files in their native formats (except for the Biogrid arrayer which is modeled through a web form). 
Enclosures allow users to attach arbitrary files to any of the MicroArray Facility objects (such as spreadsheet results, publications, images etc.).
Table 2: List of objects that can be stored and queried from the 
MicroArray Facility web interface.
Clone annotation Vector hybridization
Clones Probe
Genes Spike
Library Oligo
Clone sequencing Hybridisation
Clone history Quantification result
PCR primer Extracts
PCR run Sample
Purified PCR run Individual organism
Plate management Parameter
Plate Extract
Plateset Extract amplification
Plate history Sample hybridization
Plateset history Experiment
Worklist Probe
Freezer Spike
Array management Hybridisation
Array Quantification result
Array batch Project
Array analytic validation Project
Array batch analytic validation User
Strip Process
Unstock Enclosure
Production Follow-Up Protocol
ProtocolBMC Genomics 2006, 7:240 http://www.biomedcentral.com/1471-2164/7/240
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PCR run form used to verify cDNA clone amplifications on agarose gels Figure 3
PCR run form used to verify cDNA clone amplifications on agarose gels. Double data submission (second table) is part of 
MicroArray Facility's quality control measures. Band readings are entered through keyboard strokes for better ergonomy and 
increased throughput.BMC Genomics 2006, 7:240 http://www.biomedcentral.com/1471-2164/7/240
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Feature extraction (image quantitation) results can be
imported in a number of common software formats such
as BZscan[49], ArrayGauge[50], Genepix[51],
Imagene[52], and ProfileSoftware[48]. Where a format is
not supported MAF provides a simple generic tab delim-
ited format that can easily be produced with a spreadsheet
program.
External controls added to labelled samples, such as RNA
spike-ins which are commonly used with Nylon filters, are
also quantitatively represented by MAF for a more accu-
rate assessment of quality control and for spike based data
set normalization.
MAF representation of biological samples links individu-
als, samples, RNA extracts and labelled extracts, each with
a many-to-many cardinality. Rich quantitative and quali-
tative annotation of both individuals and samples is sup-
ported (e.g. code, age, mass, sex, tumor grade etc.), using
either standard nomenclatures (such as oncology terms)
or user defined parameters. This controlled vocabulary
annotation of samples is of paramount importance for
effective downstream correlation of expression profiles
with experimental, biological and clinical factors.
Data annotation and MIAME compliance
Results from high throughput gene expression profiling
experiments differ from single gene measurements in that
the effects of many more experimental parameters are
likely to be observed. The proper correlation of expression
signatures with biological parameters therefore requires
careful recording of all known experimental variables.
This long recognized specificity of transcriptome analysis
has led the Microarray Gene Expression Data Society
(MGED[53]) to draw up MIAME, a set of minimal anno-
tation guidelines for microarray based experiments[39].
All three international gene expression archives support
MIAME standard data annotation, and an increasing
number of scientific editors are requiring MIAME grade
data for publication in their journals[23].
Thus MIAME compatibility has been a design ambition
for the development of MicroArray Facility since its incep-
tion. This has directly impacted the underlying MAF data
scheme as can still be seen in the [individual > sample >
extract > labeled extract] part of the model. Defined name
spaces for MIAME annotation are reserved in all relevant
parts of the database relations. The annotation is either
collected through web forms from the user (e.g. hybridi-
zation protocol), or generated automatically by MAF
using imported public data (e.g. gene symbols from ENT-
REZ GENE or SWISSPROT).
Pivotal in MIAME is the requirement to attach laboratory
protocols for all experimental steps. MAF has 15 protocol
categories which are user supplied documents (e.g. text or
PDF files) supplemented with optional or obligatory var-
iable parameters, e.g. exposure time for "Image Acquisi-
tion" protocols.
Since software can only be 'MIAME supportive', i.e. poten-
tially able to store the required annotation, MAF provides
a MIAME check-list to help researchers make sure their
data is actually MIAME compliant. The check list, accessi-
ble at any time, reports any missing annotation, in partic-
ular required protocols currently undefined in the project.
Data export and interoperability
Data collected through the forms and their associated
annotations can be viewed at any time through specific
web reports launched from the permanent search box in
the form header. All reports are dynamically hyper linked
facilitating navigation across object categories. Displayed
data can also be directly downloaded as tabulated text
files. A more substantial reporting tool is also provided for
more transversal data searches, such as finding all samples
verifying specific criteria, for instance tumor grade or
patient age. Search results are exported as classical flat file
datasets including comprehensive sample and reporter
annotations as well as the expression measurements. This
text file format is compatible with most downstream anal-
ysis tools such as BioConductor, Cluster or ProfileSoft-
ware [46-48].
MAF also currently provides an experimental MAGE-ML
complete experiment export functionality comprising all
MAGE packages (ArrayDesign, DesignElement, Experi-
ment, BioAssay, BioMaterial, BioAssayData) suitable for
exporting to data archives or to MAGE-ML enabled data
analysis tools[47]. The MAF produced MAGE-ML has
been validated and a test experiment was successfully
pipelined into ArrayExpress.
Regulatory compliance
Regulatory agencies are currently working to define a
proper regulatory environment for GEP use in drug devel-
opment and market approval processes. A guidance on
Pharmacogenomic Data Submissions was issued by the
FDA in March 2005[54]. This document defines the rules
to be followed in order to ensure that GEP data submitted
for drug approval will have the quality level required by
the FDA.
Compliance with FDA 21 CFR part 11 regulations is
audited at least once a year. The production version of
MAF is currently 80% compliant with 21 CFR part 11.
Ongoing developments aim to reach full MAF compliance
with Good Laboratory Practices (GLPs). Guidelines forB
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Table 3: Comparison of microarray LIMS with regard to licencing, specific technology support, regulatory compliance, MIAME compliance and Mage-ML export.
Name Supplier Specific Support for License Type Regulatory Compliance MIAME Mage-ML export
Nylon filters 2-color slides Oligo chips 21 CFR part 11
ArrayDB 2.1 National Human Genome Research Institute 
(NHGRI)
** O S * * *
BASE 1.2 Lund University ± OS *
GeneX Va/GEOSS 2.5.2 University of Virginia * ± OS * *
LIMaS 2 Medical Research Council (MRC) Harwell * RF *
MADAM The Institute for Genomic Research (TIGR) ± OS *
MADGE University of Florida * * RF * * *
MARS 1.1.1 Graz University of Technology * * RF *
maxdLoad2 University of Manchester * OS *
MicroArray Facility Ipsogen/Institut National de la Santé et de la 
Recherche Médicale (INSERM)
±R F
MicroGen Politecnico di Milano * * OS * *
MiMiR Imperial College London * * RF *
QuickLIMS German Cancer Research Institute * * RF * * *
SMD/Longhorn Array 
Database 1.5
Stanford University * * OS *
Acuity 4.0 Molecular Devices * Com *
Expressionist GeneData * Com
GeneDirector 3 BioDiscovery * Com * *
GeneSpring GX 
Workgroup
Agilent technologies Com
GeneTraffic(Multi) Stratagene Com *
PARTISAN arrayLIMS Clondiag Com *
Resolver 6.0 Rosetta Biosoftware Com
OS: Open Source, RF: Royalty Free licence for academics, Com: Commercial Licence, 21 CFR part 11: aimed to comply with U. S. Food and Drug Administration Guidance for Industry [54], ± : partially 
supported feature, *: unsupported feature or feature not described in software associated documentation, website or publications.
9
9 9 9 9
9 9
9 9 9 9
9 9 9 9
9
9 9 9
9 9 9 9
9 9 9 9 9
9 9
9 9 9
9
9 9 9
9 9 9 9
9 9 9 9 9
9 9 9
9 9 9 9 9 9
9 9 9 9 9
9 9 9 9 9
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archiving records and standard operating procedures
(SOPs) are distributed with the commercial version of the
MAF (Discovery Software, see licensing).
Conclusion
We have developed MicroArray Facility, a software tool for
the management of microarrays which offers extended
Nylon functionalities not found in other freely available
LIMS (Table 3). All gene expression profiling steps from
cDNA clone management to spot measurements are rep-
resented in the MAF database with annotation granularity
compatible with MIAME.
Importantly, the MAF system has been tried and tested in
both academic shared facilities and industrial environ-
ments managing cDNA and Affymetrix gene expression
projects. Running in production for five years, MAF has
established itself as a central information hub in the labo-
ratory. Investment in data entry is rewarded by providing
researchers with fast answers to common queries (e.g.
"what is the expression profile of this new marker in our
previously tested tumors?") and by helping extract more
biological meaning from collected data.
Availability and requirements
• Project name: MicroArray Facility (MAF)
•  Project home page: http://tagc.univ-mrs.fr/bioinfor
matics/maf/
• Operating system(s): Platform independent
• Programming language: Perl, SQL
• Other requirements: Web Server (e.g. Apache), RDBMS
(Oracle or PostgreSQL), MAGEstk
• Licensing: Royalty free, non-exclusive, non-transferable
INSERM license for academics (excluding SOPs)
• Any restrictions to use by non-academics: Discovery
Software license from IPSOGEN SAS
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